Bingbing Lu

149 Dalian Road
Zunyi, 563000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Targeting HDAC2 with bruceine D epigenetically restores SMAD3 expression via H4K16ac enrichment to suppress malignant progression in EGFR-TKI-resistant lung adenocarcinoma.

Targeting HDAC2 with bruceine D epigenetically restores SMAD3 expression via H4K16ac enrichment to suppress malignant progression in EGFR-TKI-resistant lung adenocarcinoma.

Journal: Journal of ethnopharmacology

Published: May 16, 2026

Circ_IGF2BP1/miR-885-3p/TK1 axis regulates the malignant phenotype and chemotherapeutic resistance of lung adenocarcinoma cells via DNA damage and apoptosis.

Circ_IGF2BP1/miR-885-3p/TK1 axis regulates the malignant phenotype and chemotherapeutic resistance of lung adenocarcinoma cells via DNA damage and apoptosis.

Journal: International journal of biological macromolecules

Published: May 06, 2025

Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches.

Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches.

Journal: Molecular cancer

Published: April 17, 2024

Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma.

Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma.

Journal: Cancer research

Published: July 27, 2023

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 12, 2023

Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer.

Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer.

Journal: Nature communications

Published: November 30, 2022

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.

Journal: Signal transduction and targeted therapy

Published: April 27, 2022

3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo.

3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo.

Journal: Journal of Cancer

Published: July 29, 2021

Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma.

Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma.

Journal: Frontiers in pharmacology

Published: June 01, 2020

Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy.

Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy.

Journal: Frontiers in oncology

Published: March 18, 2020

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo.

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 22, 2020

CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.

CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.

Journal: Carcinogenesis

Published: November 20, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026